IMM/Test is a prototype software tool built to generate test cases that can be used to help test and verify the internal logic of an immunization forecasting program. A forecasting program takes as input a child's immunization history and produces recommendations as to which vaccinations are due and which should be scheduled next. IMM/Test was developed to test a specific immunization forecasting program, IMM/Serve. In addition, IMM/Test has been incorporated into a broader Web-based tool, IMM/Web, which allows the user (e.g., a member of an immunization registry staff ) to customize the parameters used for immunization forecasting (e.g., the minimum ages for each dose and the minimum wait intervals between doses) to reflect local practice. IMM/Web then generates a customized set of test cases that may be used to test the user's immunization forecasting program. The user may also request that the test cases be automatically passed to IMM/Serve to analyze using the newly defined parameters. The paper describes the internal design of IMM/Test and IMM/Web and discusses certain lessons learned in the implementation of the two programs.
INTRODUCTION
A growing number of states and health organizations are implementing computer-based childhood immunization registries that record the immunization histories of the children being served (1) . Once these histories are online, a natural next step is to process the data automatically for several related purposes, including (1) immunization forecasting (indicating which vaccine doses are due now and which should be scheduled next), (2) reminder and recall (generating lists of patients to be contacted for vaccinations which are due or past due), and (3) compliance assessment (analyzing how well the immunization status of a population of patients meets desired goals).
A number of immunization registries already use programs that perform some or all of these functions. A major current need is for test cases that can be used to help validate the logic contained in these programs. A fundamental question concerns how best to meet this need. One approach is to develop a static set of exploring how an immunization registry could generate test cases for use in testing any immunization forecasting program, not just IMM/Serve. In addition, IMM/Web allows the new test cases to be passed automatically to IMM/Serve to be analyzed using the newly defined parameters, allowing the user to see what IMM/Serve considers to be the correct forecast for each case. The IMM/Web project is thereby exploring how the Web can be used to help in the process of immunization knowledge maintenance.
The paper first discusses a number of background issues to place the project into perspective. It then gives an example of IMM/Web in operation and describes the internal design of both IMM/Test and IMM/Web. Finally, it discusses the current status of the project and a number of the lessons learned during its implementation.
BACKGROUND
The overall problem of validating and evaluating clinical advice-giving programs is a diverse research area which spans many different aspects of the problem (6) (7) (8) . The IMM/Test project focuses on one particular aspect, the generation of test cases to help validate the operation of a computer-based guideline built to produce patient-specific advice.
There is no way to prove rigorously that a complex computer program functions correctly. In fact, except for very constrained programs, it can be proved that the correct behavior of a computer program is inherently unprovable (9) . As a result, one must develop test cases that help validate a program as best one can within the practical constraints of what is possible and what is needed in a particular domain.
Two general approaches to testing a computer program are (1) a ''white box'' approach where the testing is tailored to the known logic contained in the program and (2) a ''black box'' approach where testing is governed by program specifications and where the logic contained within any particular program is not considered (10) . IMM/Test's approach is definitely a ''white box'' approach. A key issue in testing a computer program concerns the degree of ''coverage,'' either of the statements in the program or of the paths through the program (11) . Another issue is ''boundary analysis,'' which involves forcing variables to take on extreme values to assure that correct behavior is still obtained (12) .
There are a variety of formal approaches that have been developed for validating a computer program with test cases, including mutation analysis (13), statebased testing (14) , and data flow testing (15) . Much of this work focuses on analyzing how well an existing static set of test cases covers a particular program's logic, using statistical measures. The prototype IMM/Test project has a different focus in that it involves automatically generating a set of test cases to assure that each of a central set of decisions in the program's logic has been exercised at least once. In addition, certain of the more formal approaches may require huge numbers of test cases (tens of thousands or more (16) ) and would therefore not be practical for our needs. In general, a complex computer-based clinical guideline requires a well-thought-out, practical strategy for testing which is tailored to the underlying problem and the domain.
AN EXAMPLE OF IMM/WEB IN OPERATION
This section introduces IMM/Web's approach to user-customized test case generation by demonstrating it in operation. The project home page (http:// ycmi.med.yale.edu/immserve) provides access to a number of different components of the project, including a Web-accessible version of IMM/Serve, a detailed description of IMM/Serve, and both IMM/Test and IMM/Web. IMM/Web is designed to be used by a member of an immunization registry staff who wants to obtain a set of test cases customized to the practice reflected in a local immunization forecasting program.
To use IMM/Web, the user first selects an immunization series for which test cases should be generated. If Hepatitis B is selected, Fig. 1 shows the Web page which displays the tabular forecasting parameters used by IMM/Serve for the three doses of Hepatitis B vaccine. For this vaccine series, each dose has three parameter sets. For dose 2 of Hepatitis B, for example, these three parameter sets are named HepB2, HepB2 -accel, and HepB2 -adolescent. Each parameter set applies in a specific clinical setting (which is described in detail if the user clicks on the ''Help'' button). If-then rules are used by IMM/Serve to determine which parameter set applies to a particular case.
1. The HepB2 -adolescent parameter set applies if the child's birthday is before 11/22/91.
2. The HepB2 parameter sets applies if the child's birthday is on or after 11/22/91, and the mother is HBsAg negative.
3. The HepB2 -accel parameter set applies if the child's birthday is on or after 11/22/91, and the mother is HBsAg positive or the mother's HBsAg status is unknown.
For each parameter set, the table specifies several immunization forecasting parameters.
1. The minimum acceptable age is the age at which the dose may be given to a child who for whatever reason happens to be at a clinic.
2. The recommended age is the age at which the dose should normally be scheduled for administration.
3. The minimum interval from the previous dose is the required wait interval to be observed between doses. For example, if dose 1 was quite late, dose 2 should not be given until after this interval has passed, even if this requires waiting past the recommended age for the dose.
4. For dose 3, there is also a required wait interval from dose 1. Most childhood vaccines only specify required wait intervals from the most recent dose of that vaccine. Hepatitis B is unusual in that its third dose requires an additional wait interval from a more distant previous dose.
This web page allows the user to modify the parameters shown to reflect any local differences in the practice of a specific registry or clinic. As a simple example,
FIG. 1.
This web page allows the tabular parameters used for forecasting Hepatitis B vaccinations to be modified to reflect the local practice of a specific clinic or immunization registry, as described in the text. the user might change the minimum acceptable age for the HepB2 parameter set from ''2 M'' (2 months) to ''6 W'' (6 weeks). More complex combined changes are also possible.
Once the desired changes are made, the user simply clicks on the ''Submit'' button to generate a set of test cases. Before sending this request to be processed, a series of JavaScript consistency checks are performed to assure that the submitted parameters are meaningful. For example, a check is made to see that the recommended age in a parameter set is not less than the minimum acceptable age. The user may also choose (using a radio button at the bottom of the web page) whether (1) acceptable ages are to be used in generating the test cases or (2) only the recommended ages should be used. (Some clinics do not use the minimum acceptable ages for forecasting.) In addition, the user may ask for a set of test cases that tests (1) all the parameter sets or (2) just those parameter sets that have been modified. If all test cases are requested, 39 test cases are generated by the current IMM/Web program for Hepatitis B. The test cases are presented to the user in a web page text box. The test cases may then be (1) copied out of the text box into a user document or (2) automatically submitted to IMM/Serve as described below.
If only a single parameter has been changed as described above, and the user has requested a focused set of test cases, then only the four cases shown in Fig.  2 are produced. These cases are designed to test the single change of ''1 M'' to ''6 W'' in the HepB2 parameter set. These test cases are written in a format which can be directly input to IMM/Serve. Each test case contains the following information.
1. The first line of each test case contains miscellaneous information about the case including the vaccine series and dose, and a somewhat terse indication of what the specific case is testing.
2. The second line (starting with ''#'') is a comment. It indicates the combination of clinical conditions that the case is designed to test. With Hepatitis B, the only condition that applies is the mother's HBsAg status, which can be ''positive,'' ''negative,'' or ''unknown,'' or if the child is ''adolescent'' the mother's HBsAg status is not relevant. Since the user has only changed one parameter set (HepB2), and that parameter set is only used when the mother is HBsAG negative, only cases testing this condition are produced.
3. The third line (also a comment) indicates the specific parameter sets (as shown in Fig. 1 ) which apply for the dose that is due for the test case and for the dose that should be scheduled next. Since in this example the user has only asked for test cases that involve a single change to the HepB2 parameter set, all the cases include that parameter set, either as the dose that is due or as the dose to be scheduled next.
4. The next two lines contain the child's birthday and the date to be used for forecasting (e.g., the date when the child is expected at the clinic).
5. The sixth line contains a list of any vaccines that should be considered contraindicated. For simplicity, to force IMM/Serve to focus its output only on Hepatitis B, all other vaccines are set as contraindicated.
6. The next line, labeled ''Other,'' contains any other information about the case, in this case the mother's HBsAg status which is negative in all four cases as described above.
7. The final line of each case shows the dates of previous Hepatitis B vaccinations (if any). These dates are automatically generated by IMM/Test (as described later in the paper) to meet the conditions to be tested by the case.
These four test cases are designed to test the following four conditions: 1. Case 1 tests the situation when HepB1 is due and HepB2 should be scheduled to follow.
2. Case 2 tests the situation when HepB2 is due (the forecast date is over 6 weeks of age and the minimum wait interval has elapsed since HepB dose 1).
Case 3 tests the situation when HepB2
is not yet due because the minimum acceptable age is not yet met (the forecast date is less than 6 weeks of age).
Case 4 tests the situation when HepB2
is not yet due because the minimum interval (1 month) has not elapsed from HepB1 (even though the forecast date is greater than the minimum acceptable age).
Hepatitis B was chosen for this example because its logic is of moderate complexity. The logic involved for the Hib, Polio, and DTP vaccine series is considerably more complex than that for Hepatitis B. This increased complexity results in an additional number of test cases generated for these vaccine series, typically testing more combinations of conditions for each dose.
If the user clicks on a ''Submit to IMM/Serve'' button, the test cases are automatically passed to IMM/Serve for its recommendations. Any newly defined parameters are also passed to IMM/Serve, so that the recommendations will reflect those changes. In this way the user may see what IMM/Serve considers to be the correct forecast for each case. Figure 3 shows IMM/Serve's recommendations for the four cases. In this figure we have removed much of the material produced by IMM/Serve (including a disclaimer, a restatement of each case, and an indication of the version of IMM/Serve and of the knowledge base used in the analysis). Notice that because all other vaccines were listed as contraindicated, the recommendations focus solely on Hepatitis B vaccine.
STAGES IN IMM/TEST'S TEST CASE GENERATION PROCESS
IMM/Test's generated cases currently test a central core of the immunization logic for the following six childhood vaccination series: Haemophilus influenzae type b (Hib), Hepatitis B (HepB), Varicella (Var), Measles Mumps Rubella (MMR), Diphtheria Tetanus Pertussis (DTP), and Polio (OPV/IPV). This logic is represented in two formats.
1. Tabular parameter sets (as seen in Fig. 1 ) are used to store the knowledge of minimum ages and wait intervals for each dose. Frequently several parameter sets must be defined for a dose to be used in different clinical contexts.
2. If-then rules are used to represent the logic which determines which parameter set should be used for a particular case. The current IMM/Test program is designed to test a central portion of this rule-based logic, the logic ''kernel'' which must respond to all combinations of input variables.
The main focus of IMM/Test's initial processing is on the various sets of clinical conditions contained in the rule-based kernel logic. The parameter sets are used at the end of IMM/Test's processing, when specific dates are produced.
IMM/Test generates test cases for a vaccine series one dose at a time. In this section, we use Hib dose 2 as an example to illustrate the steps which IMM/Test takes in generating test cases. This example was chosen because the logic involved is reasonably complex and therefore illustrates well the issues that arise.
Specifying sets of mutually exclusive conditions. The first step taken by IMM/Test to prepare test cases for a specific dose of a vaccine series is to collect all the conditions tested in the rules and arrange those conditions into sets of mutually exclusive conditions. (In fact, these conditions are not taken directly from IMM/Serve's if-then rules, but rather from a simplified representation of the logic, ''immunization definition logic,'' from which the rule kernel can be automatically generated. An explicit description and discussion of the Hib definition logic and rule kernel is provided in a companion paper (17) .)
For Hib dose 2, there are four sets of mutually exclusive conditions as shown below.
1.
[ Two of these sets (condition sets 1 and 4) test the patient's age in months when Hib dose 1 was given. (These two related sets of conditions are tested in different parts of the logic for Hib dose 2.) Condition set 2 tests whether the vaccine brand PRPOMP was used for Hib dose 1. Condition set 3 tests the current age in months of the patient.
Generating all combinations of the conditions. The next step involves generating a list of all combinations of the conditions. This requires taking the ''dot product'' of the four sets of conditions and therefore generates 24 (3 ϫ 2 ϫ 2 ϫ 2) different combinations. Eight examples of these 24 combinations are shown below.
[ The first constraint indicates that if Hib dose 1 was given after 15 months of age, that combination will not occur. This is a somewhat artifactual constraint and occurs because the child would not require further doses in this situation. Other logic in the program would declare the vaccine series to be complete and the Hib dose 2 logic would therefore never be executed. Constraints 2 and 3 are logically impossible for obvious reasons.
Application of these three constraints to the 24 combinations eliminates 14 combinations, leaving 10 combinations for further processing in the test generation process. Of the 8 combinations shown above, the following 4 survive this elimination process.
2.
[ Determine which parameter sets apply for each combination. To be able to generate a test case, IMM/Test not only needs to have a combination of conditions from the rules, it also needs to know which set of parameters apply for that combination of conditions, both for the dose which is due and for the dose which will be scheduled next. To make this determination, IMM/Test runs each combination of conditions through the rule-based logic (actually through the ''definition logic'' from which the rules can be derived). For example, performing this analysis for combination 6 above, determines that the parameter set ''Hib2'' applies to the dose which is due and the parameter set ''Hib3 -final'' applies to the dose which should be scheduled to follow. These parameter sets are defined as follows. This logic has the following meaning. 1. The date, 1/1/94, will be used as a basis for determining the patient's birth date. (IMM/Test randomly selects a birth date for the test case from the 100-day period following this date.) 2. Unless other conditions take priority as described below, the parameter set ''Hib1'' will be used to determine when dose 1 was given after the birth date selected. (Hib dose 1 will be part of the history included in the test cases generated for this combination.) The Hib1 parameter set indicates an acceptable minimum age of 6 weeks and a recommended age of 2 months. Since this is the first Hib dose there is no wait interval from a previous dose.
3. Hib dose 1 should be at least 7 months after the birth date selected. (Since 7 months is greater than the minimum age specified in the Hib1 parameter set, this clause will take priority in choosing a date for Hib dose 1.)
4. The patient's age (e.g., the forecast date for which the analysis should be run) should be at least 12 months after the birth date selected.
Generating one or more test cases for each combination. The final step of the test generation process involves taking the case generation logic and generating one or more test cases for each combination. For the example combination described above, the following three cases are generated by the current version of IMM/Test. To allow the user to understand the conditions being tested in each test case, those conditions are included as comments in each case, along with the two parameter sets involved. Since these three cases all involve the same combination of conditions, these comments are identical in all three cases, as is the birth date. The same first Hib dose is also used, chosen to be at least 7 months after the birth date, as discussed above. Since this is the fourth of the combinations which ''survived'' elimination by constraints, on line 1 these cases are labeled as involving condition set (combination) 4. Each of these 3 cases is designed to test a different feature of the immunization forecasting logic for this combination of conditions.
1. In case 19, the forecast date is selected to be slightly over the minimum age of 12 months specified in the conditions, so that Hib dose 2 should be due and Hib dose 3 should be scheduled next.
2. In case 20, the forecast date is selected to be slightly under the minimum age of 12 months, so that Hib dose 2 is not yet due.
3. In case 21, Hib dose 2 is listed as given, and a date is used for the forecast which is over the maximum age for Hib vaccination. In this case, the Hib vaccine series should be identified as ''completed or no longer relevant.'' This case tests that the maximum age limit for the Hib series applies correctly in this combination of conditions.
Depending on the conditions involved, IMM/Serve will generate a different number of test cases and/or different types of test cases. In our example, the due date was determined by a late age threshold (12 months) derived from the rule-based logic. More typically (as was illustrated in the example discussed in Section 3 and Fig. 2) , the due date is determined by the parameter set listed as ''due'' as described above. If so, a test case is typically generated for each of the following situations: (1) one test case satisfies the parameter set, (2) one test case fails the parameter set because the forecast date is before the minimum age, and (3) one test case fails the parameter set because the forecast date is before the wait interval has elapsed, despite the fact that it is above the minimum age. Table 1 shows, for each dose of each vaccine series, the number of sets of mutually exclusive conditions, the total number of conditions, and the number of test cases generated by the current IMM/Test program. As discussed later in more detail, the set of test cases generated reflects the underlying algorithmic strategy chosen. IMM/Test's current design represents an early attempt to define how such a strategy might best be formulated.
The generality of the algorithm. It is important to point out that a single version of the IMM/Test program is able to operate for all six vaccine series. For each vaccine series, IMM/Test accepts as input data structures which include: (1) the ''definition logic'' from which the various conditions are extracted, (2) a table of mutually exclusive conditions, (3) a table of constraints, (4) a table of redundant conditions, and (5) a table containing the translation logic, as described above. Based on this information, IMM/Test generates its test cases.
THE DESIGN OF IMM/WEB
IMM/Test was developed to help test the logic of IMM/Serve and therefore incorporates IMM/Serve's logic. IMM/Web was developed to generalize IMM/ Test's approach to produce user-customized test cases and to make them conveniently available via the Web. IMM/Web allows customization of the tabular parameter sets used in immunization forecasting, but not of the logic contained in the rules. Figure 4 provides a schematic overview of how IMM/Test and IMM/Serve are incorporated into the operation of IMM/Web. The dark arrows show the interaction with the user from one web page to the next. The light arrows provide a simplified outline of the flow of data as user-customized parameters are passed to IMM/Test to allow the generation of user-customized test cases. These cases are presented to the user via the Web. These customized test cases along with the customized parameter sets are then passed to IMM/Serve, which produces a web page containing its recommendations for each case using the newly defined parameters.
CURRENT STATUS AND FUTURE DIRECTIONS
IMM/Test and IMM/Web are prototypes designed to demonstrate the approach and to provide initial experience with the issues involved. The test cases currently cover a central and important set of conditions. The set of conditions is not, however, in any way complete. There are a range of other conditions that might be tested. These include:
1. the immunization screening logic (which uses minimum ages and wait intervals to flag previous doses as ''invalid''), 2. the interactions between live vaccines (which must in general be given either at the same time or at least 30 days apart), 3 . the logic that determines the appropriate brand or preparation to be given (which is only relevant for certain vaccine series), 4. assuring that the temporal logic embedded in the program deals appropriately with idiosyncracies such as months of different length, leap years, and the year 2000, 5 . assuring that the logic tested independently for each vaccine series still works correctly when multiple vaccines are analyzed together.
Even in its current prototype form, however, we believe that IMM/Web can be productively used by immunization registries and software developers to help test their forecasting programs. As a result, an important next step will be to start to work with registries, in addition to using the programs to test our own forecasting program (IMM/Serve), to gain experience with the approach in real-world settings.
LESSONS LEARNED
This section discusses some of the issues that arose and lessons learned in the process of building the prototype version of IMM/Test and IMM/Web described in this paper.
Developing and Exploring Strategies for Immunization Test Case Generation
One issue that became very clear in the process of building IMM/Test is that there is not a single approach to generating test cases for an immunization forecasting program. It will therefore be important to explore a range of strategies to see which set of strategies is most appropriate. In addition, the most appropriate approach for testing an immunization forecasting program will likely depend on its internal program structure and will therefore differ for different forecasting programs.
The strategy currently taken by IMM/Test has been to take the ''dot product'' of a core set of clinical conditions and to generate one or more cases for each combination of conditions. As discussed previously, the present prototype is not comprehensive. To fully implement this basic approach will require generating test cases to test other aspects of the program's logic.
Even when implementing this seemingly quite straight-forward strategy, several interesting questions arise which illustrate the type of issue that must be confronted in developing a comprehensive strategy.
1. Certain vaccine series involve a maximum age. IMM/Serve's logic typically tests this age once for each vaccine series. If the maximum age is exceeded, a single rule disables all the logic for that series. As a result of this design, it is probably not necessary to test whether the maximum age is correctly handled for every combination of clinical conditions. If the logic is working in one set of clinical conditions, or at least in a few different cases, then it is presumably working for all cases.
2. Making sure that an immunization forecasting program deals correctly with dates is another major issue. IMM/Serve currently generates a birth date randomly from a range of 100 days after a specified date, and then selects the other dates in a test case using calculations based directly or indirectly on the birth date. This approach does not allow one to assess systematically whether IMM/Serve deals correctly with issues such as the different lengths of months, leap years, the year 2000, etc. One would need to generate a large number of test cases, with many different birth dates chosen much more systematically, to even begin to test these issues. It would be more reasonable, however, to examine the internal module within the forecasting program which combines dates and time intervals to determine future dates, and run a systematic test of that module in isolation (testing the logic with dates and intervals, not with entire immunization histories), to assure that logic involving dates is being handled correctly.
These are two representative issues that will need to be dealt with in developing a well-thought-out strategy for immunization test case generation and for the underlying problem of validation of an immunization forecasting program.
The Need for Immunization Domain Knowledge in a Test Case Generation Program
Some clinical guidelines may only involve clinical conditions which are discrete events or conditions (such as a history of a coronary artery bypass graft operation or the presence of end stage chronic renal failure). For such guidelines, there may be a direct translation between a set of clinical conditions and a corresponding test case. In part because of the highly temporal nature of the immunization guideline and the need for IMM/Test to construct a history of up to five previous doses in a vaccine series, it is not straightforward to convert a set of clinical conditions into a test case. Domain knowledge must be encoded into the computer to allow this. This domain knowledge is in part contained in the case generation translation table (described in Section 5) and in the routines that operate on the case generation logic to create specific test case dates.
Because of this requirement and others, the IMM/Test program is highly domain-specific and could not be readily adapted to deal with other clinical guidelines. It would in all likelihood be easier to build a test case generator for a different clinical guideline completely from scratch than to try to adapt IMM/Test. From a broader standpoint, the implication of this observation is that very different tools for knowledge testing may be required for different clinical guidelines. If so, the overall cost of ''computerizing'' a complex guideline may be significantly higher than anticipated, since customized computer-based tools may need to be built as well. These issues can only be explored over time as more and more clinical guidelines are placed into operational computerbased form.
Allowing the User to Modify Parameters vs Rules
IMM/Web currently allows the user to customize the immunization forecasting parameter sets, but not the underlying rules. This is a deliberate decision. The tabular parameters are quite easy to read, understand, and modify, although one does need to appreciate the clinical logic that determines which parameter set applies to a particular case. (A description of this logic is available to IMM/Web's user through a ''Help'' button.) In contrast, it requires a great deal of sophistication to understand, modify, and test the rules. As a result, we anticipate that, at least for the foreseeable future, modifications to the rules will only be made by a knowledge engineer who is intimately familiar with those rules and with how they fit into IMM/Serve's operation as a whole.
SUMMARY
There is currently a major national initiative to place clinical guidelines into computer-based form so that they can provide patient-specific advice. The problem of creating a complex computer-based guideline, maintaining the knowledge as the clinical field evolves, and assuring that all versions of the guideline provide correct advice is a major challenge. It will be important to develop computerbased tools to assist in this guideline knowledge maintenance process. IMM/Test and IMM/Web are examples of such tools. An interesting observation is that both the computer-based guideline and the software tools required to maintain the knowledge are of significant and comparable complexity. This suggests that the effort to fully operationalize a computer-based version of a complex clinical guideline may require a significant additional task to develop such tools.
The development of IMM/Test and IMM/Web represents one step in the process of exploring (1) how best to approach these problems and (2) the magnitude of the task involved.
